The American Journal of Medicine
Volume 118, Issue 3 , Pages 212-216 , March 2005

Toxoplasmosis in pregnancy

  • Jeffrey D. Kravetz, MD

      Affiliations

    • Yale University School of Medicine, New Haven, Connecticut, and Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut
    • Corresponding Author InformationRequests for reprints should be addressed to Jeffrey D. Kravetz, MD, 950 Campbell Avenue, 11ACSL, West Haven, Connecticut 06516
    • ,
  • Daniel G. Federman, MD

      Affiliations

    • Yale University School of Medicine, New Haven, Connecticut, and Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut

Received 18 March 2004 ,Accepted 10 August 2004.

References 

  1. Kravetz JD , Federman DG . Cat-associated zoonoses . Arch Intern Med. . 2002;162:1945–1952
  2. Jones JL , Kruszon-Moran D , Wilson M , et al.   Toxoplasma gondii infection in the United States (seroprevalence and risk factors) . Am J Epidemiol. . 2001;154:357–365
  3. Mead PS , Slutsker L , Dietz V , et al.   Food-related illness and death in the United States . Emerg Infect Dis. . 1999;5:607–625
  4. Centers for Disease Control and Prevention . CDC Recommendations regarding selected conditions affecting women’s health . MMWR Morb Mortal Wkly Rep. . 2000;49:59–68
  5. Markell EK , John DT , Krotoski WA . Toxoplasma gondii . In: Markell and Voges’s Medical Parisitology . 8th ed.. Philadelphia, Pennsylvania: W.B. Saunders Co; 1999;p. 161–171
  6. Despommier DD , Gwadz RW , Hotez PJ . Toxoplasma gondii . In: Parasitic Diseases . 3rd ed.. New York, New York: Springer-Verlag; 1995;p. 162–169
  7. Beazley DM , Egerman RS . Toxoplasmosis . Semin Perinatol. . 1998;22:332–338
  8. Dubey JP . Strategies to reduce transmission of Toxoplasma gondii to animals and humans . Vet Parasitol. . 1996;64:65–70
  9. Mombro M , Perathoner C , Leone A , et al.   Congenital toxoplasmosis (assessment of risk to newborns in confirmed and uncertain maternal infection) . Eur J Pediatr. . 2003;162:703–706
  10. Montoya JG , Liesenfeld O . Toxoplasmosis . Lancet . 2004;363:1965–1976
  11. Kapperud G , Jenum PA , Stray-Pedersen B . Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway . Am J Epidemiol. . 1996;144:405–412
  12. Bobic B , Jevremovic I , Marinkovic J . Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia . Eur J Epidemiol. . 1998;14:605–610
  13. Baril L , Ancelle T , Goulet V , et al.   Risk factors for Toxoplasma infection in pregnancy (a case-control study in France) . Scand J Infect Dis. . 1999;31:305–309
  14. Cook AJ , Gilbert RE , Buffolano W , et al.   Sources of toxoplasma infection in pregnant women (European multicentre case-control study) . BMJ . 2000;321:142–147
  15. Jones JL , Ogunmodede F , Scheftel J , et al.   Toxoplasmosis-related knowledge and practices among pregnant women in the United States . Infect Dis Obstet Gynecol. . 2003;11:139–145
  16. Jones JL , Dietz VJ , Power M , et al.   Survey of obstetricians-gynecologists in the United States about toxoplasmosis . Infect Dis Obstet Gynecol. . 2001;9:23–31
  17. Pawlowski ZS , Gromadecka-Sutkiewicz M , Skommer J , et al.   Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis (the experience of Poznan, Poland) . Health Educ Res. . 2001;16:493–502
  18. Foulon W , Naessens A , Ho-Yen D . Prevention of congenital toxoplasmosis . J Perinat Med. . 2000;28:337–345
  19. Gras L , Gilbert RE , Wallon M , et al.   Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy (implications for clinical practice and cross-sectional incidence studies) . Epidemiol Infect. . 2004;132:541–548
  20. Jenum PA , Stray-Pedersen B , Melby KK , et al.   Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women . J Clin Microbiol. . 1998;36:2900–2906
  21. Liesenfeld O , Press C , Montoya JG , et al.   False-positive results in immunoglobulin M (IgM) Toxoplasma antibody tests and the importance of confirmatory testing (the platelia toxo IgM test) . J Clin Microbiol. . 1997;35:174–178
  22. Szenasi Z , Ozsvar Z , Nagy E , et al.   Prevention of congenital toxoplasmosis in Szeged, Hungary . Int J Epidemiol. . 1997;26:428–435
  23. Ricci M , Pentimalli H , Thaller R , et al.   Screening and prevention of congenital toxoplasmosis (an effectiveness study in a population with a high infection rate) . J Matern Fetal Med. . 2003;14:398–403
  24. Gilbert R , Gras L . European multicentre study on congenital toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii . BJOG . 2003;110:112–120
  25. Wallon M , Liou C , Garner P , Peyron F . Congenital toxoplasmosis (systematic review of evidence of efficacy of treatment in pregnancy) . BMJ . 1999;318:1511–1514

PII: S0002-9343(04)00700-4

doi: 10.1016/j.amjmed.2004.08.023

The American Journal of Medicine
Volume 118, Issue 3 , Pages 212-216 , March 2005

Article Tools